Solution synthesis of human midkine, a novel heparin-binding neurotrophic factor consisting of 121 amino acid residues with five disulphide bonds

Journal of Peptide Science

Volumn 2, Issue 1, 1996, Pages 28-39

  Inui, Tatsuya ^a   Bódi, József ^a   Kubo, Shigeru ^a   Nishio, Hideki ^a   Kimura, Terutoshi ^a   Kojima, Soichi ^b   Maruta, Hiroshi ^c   Muramatsu, Takashi ^d   Sakakibara, Shumpei ^a  

^a Protein Research Foundation   (Japan)

^b RIKEN TSUKUBA INSTITUTE   (Japan)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Active region; Disulphide structure; Human midkine; Powerful solvent system; Solution synthesis

Indexed keywords

CARRIER PROTEIN; CYTOKINE; DISULFIDE; MIDKINE;

AMINO ACID SEQUENCE; ARTICLE; CELL SURVIVAL; CHEMISTRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MOLECULAR GENETICS; PEPTIDE MAPPING; SOLUTION AND SOLUBILITY; SYNTHESIS;

AMINO ACID SEQUENCE; CARRIER PROTEINS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; DISULFIDES; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE MAPPING; SOLUTIONS;

EID: 0029677674     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1387(199601)2:1<28::AID-PSC45>3.0.CO;2-V     Document Type: Article

References (24)

1. P. E. Dawson, T. W. Muir, I. Clark-Lewis and S. B. H. Kent (1994). Synthesis of proteins by native chemical ligation. Science 266, 776-779.
2. T. Kimura, M. Takai, Y. Masui, T. Morikawa and S. Sakakibara (1981). Strategy for the synthesis of large peptides: An application to the total synthesis of human parathyroid hormone [hPTH(1-84)]. Biopolymers 20, 1823-1832.
3. T. Kimura, N. Chino, S. Kumagaye, H. Kuroda, J. Emura and S. Sakakibara (1990). Strategy for the chemical synthesis of large peptides; synthesis of angiogenin as an example. Biochem. Soc. Trans. 18, 1297-1299.
4. M. Narita, T. Fukunaga, A. Wakabayashi, K. Ishikawa and H. Nakano (1984). Syntheses and properties of tertiary peptide bond-containing polypeptides. I. Syntheses and properties of oligo-(L-leucine)-containing proline or glycyl-N-(2,4-dimethoxybenzyl)-L-leucine residues. Int J. Peptide Protein Res. 23, 306-314.
5. M. Narita, K. Ishikawa, J.-Y. Chen and Y. Kim (1984). Prediction and improvement of protected peptide solubility in organic solvents. Int J. Peptide Protein Res. 24, 580-587.
6. H. Kuroda, Y.-N. chen, T. Kimura and S. Sakakibara (1992). Powerful solvent systems useful for the synthesis of sparingly-soluble peptides in solution. Int. J. Peptide Protein Res. 40, 294-299.
7. H. Nishio, K. Yoshizawa-Kumagaye, S. Kubo, Y.-N. Chen, A. Momiyama, T. Takahashi, T. Kimura and S. Sakakibara (1993). Synthesis of ω-agatoxin IVA and its related peptides. Biochem. Biophys. Res. Commun. 196, 1447-1453.
8. H. Kuroda, Y.-N. Chen, T. X. Watanabe, T. Kimura and S. Sakakibara (1992). Solution synthesis of calciseptine, an L-type specific calcium channel blocker. Peptide Res. 5, 265-268.
9. S. Sakakibara (1995). Synthesis of large peptides in solution. Biopolymers (Peptide Science.) 37, 17-28.
10. L. Fabri, H. Maruta, H. Muramatsu, T. Muramatsu, R. J. Simpson, A. W. Burgess and E. C. Nice (1993). Structural characterization of native and recombinant forms of the neurotrophic cytokine MK. J. Chromatog. 646, 213-226.
11. K. Kadomatsu, M. Tomomura and T. Muramatsu (1988). cDNA cloning and sequencing of a new gene intensely expressed in early differentiation stages of embryonal carcinoma cells and in mid-gestation period of mouse embryogenesis. Biochem. Biophys. Res. Commun. 151, 1312-1318.
12. H. Maruta, P. F. Bartlett, V. Nurcombe, M. S. A. Nur-E-Kamal, C. Chomienne, T. Muramatsu, H. Muramatsu, L. Fabri, E. Nice and A. W. Burgess (1993). Midkine (MK), a retinoic acid (RA)-inducible gene product, produced in E. coli acts on neuronal and HL60 leukemia cells. Growth Factors 8, 119-134.
13. J. Tsutsui, K. Kadomatsu, S. Matsubara, A. Nakagawara, M. Hamanoue, S. Takao, H. Shimazu, Y. Ohi and T. Muramatsu (1993). A new family of heparin-binding growth/differentiation factors: Increased midkine expression in Wilms' Tumor and other human carcinomas. Cancer Res. 53, 1281-1285.
14. O. Yasuhara, H. Muramatsu, S. U. Kim, T. Muramatsu, H. Maruta and P. L. McGeer (1993). Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. Biochem. Biophys. Res. Commun. 192, 246-251.
15. S. Kojima, T. Inui, T. Kimura, S. Sakakibara, H. Maruta, H. Amanuma, H. Maruta and T. Muramatsu (1995). Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells. Biochem. Biophys. Res. Commun. 206, 468-473.
16. S. Kojima, H. Muramatsu, H. Amanuma and T. Muramatsu (1995). Midkine enhances fibrinolytiac activity of bovine endothelial cells. J. Biol. Chem. 270, 9590-9596.
17. H. Muramatsu and T. Muramatsu (1991). Purification of recombinant midkine and examination of its biological activites: Functional comparison of new heparin binding factors. Biochem. Biophys. Res. Commun. 177, 652-658.
18. H. Muramatsu, H. Shirahama, S. Yonezawa, H. Maruta and T. Muramatsu (1993). Midkine, a retinoic acid-inducible growth/differentiation factor: Immunological evidence for the function and distribution. Dev. Biol. 159, 392-401.
19. M. Nakata, T. Kimura and S. Sakakibara, in preparation.
20. + channel blocker. Biochem. Biophys. Res. Commun. 170, 684-690.
21. +-ATPase inhibitor-I (SPAI-I). Peptide Res. 5, 227-232.
22. N. Fujii and H. Yajima (1981). Total synthesis of bovine pancreatic ribonuclease A. Part 6. Synthesis of RNase A with full enzyme activity. J. Chem. Soc. Perkin Trans. I, 831-841.
23. H. Nishio, T. Kimura and S. Sakakibara (1994). Side reaction in peptide synthesis: Modification of tryptophan during treatment with mercury (II) acetate/2-mercaptoethanol in aqueous acetic acid. Tetrahedron Lett 35, 1239-1242.
24. H. Muramatsu, T. Inui, T. Kimura, S. Sakakibara, X.-J. Song, H. Maruta and T. Muramatsu (1994). Localization of heparin-binding, neurite outgrowth and antigenic regions in midkine molecule. Biochem. Biophys. Res. Commun. 203, 1131-1139.